Aparicio, Thomas

Bevacizumab Maintenance Versus No Maintenance During Chemotherapy-Free Intervals in Metastatic Colorectal Cancer: A Randomized Phase III Trial (PRODIGE 9)

Aparicio, T., Ghiringhelli, F., Boige, V., Le Malicot, K., Taieb, J., Bouché, O., Phelip, J.-M., François, E., Borel, C., Faroux, R., et al. (2018) · Journal of Clinical Oncology

Colorectal Cancer Treatments and StudiesColorectal Cancer Surgical Treatments

Cited by 91

The cellular prion protein controls the mesenchymal-like molecular subtype and predicts disease outcome in colorectal cancer

Le Corre, D., Ghazi, A., Balogoun, R., Pilati, C., Aparicio, T., Martin-Lannerée, S., Marisa, L., Djouadi, F., Poindessous, V., Crozet, C., et al. (2019) · eBioMedicine

Cancer Cells and MetastasisColorectal Cancer Treatments and Studies

Cited by 48

Bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: A meta-analysis of individual patients’ data from 3 phase III studies

Salvatore, L., Bria, E., Sperduti, I., Hinke, A., Hegewisch-Becker, S., Aparicio, T., Le Malicot, K., Boige, V., Koeberle, D., Baertschi, D., et al. (2021) · Cancer Treatment Reviews

Colorectal Cancer Treatments and StudiesColorectal Cancer Surgical Treatments

Cited by 26

Prognostic value of the PrP C -ILK-IDO1 axis in the mesenchymal colorectal cancer subtype

Ghazi, A., Le Corre, D., Pilati, C., Taieb, J., Aparicio, T., Didelot, A., Dedhar, S., Mulot, C., Le Malicot, K., Djouadi, F., et al. (2021) · OncoImmunology

Colorectal Cancer Treatments and StudiesCancer Cells and Metastasis

Cited by 21